Afyounian Ebrahim
Computational Analysis of Multilevel High-throughput Data from Cancer Tissue
https://urn.fi/URN:ISBN:978-952-03-3224-2
2024-01-12
Eerola Sini
The Role of PIM Kinases in Prostate Cancer : Promoting and Inhibiting Factors
https://urn.fi/URN:ISBN:978-952-03-2316-5
2022-03-11
Kimmo Kartasalo
Computational methods provide new tools for pathologists
http://urn.fi/URN:ISBN:978-952-03-1953-3
May 21, 2021 |
Tommi Rantapero
Developing a Framework for Analysis of Next-Generation Sequencing Data in Cancer Genetics and Epigenetics
October 16, 2020
http://urn.fi/URN:ISBN:978-952-03-1703-4 |
Kalle Kaapu
Antiarrythmic Drugs and Cancer In Finnish Men : An epidemiological study on prostate cancer risk, survival and overall cancer mortality
2019
http://urn.fi/URN:ISBN:978-952-03-1343-2 |

Thea Veitonmäki
Non-steroidal anti-inflammatory drugs and cancer in Finnish men. An epidemiologic study on prostate cancer risk, survival and overall cancer mortality
2016
http://urn.fi/URN:ISBN:978-952-03-0104-0 |
Virpi Laitinen
Genetic risk factors for hereditary prostate cancer in Finland – From targeted analysis of susceptibility loci to genome-wide copy number variation study
Acta Electronica Universitatis Tamperensis; 2016
http://urn.fi/URN:ISBN:978-952-03-0144-6 |
Riikka Nurminen
Genetic Susceptibility Factors for Prostate Cancer at Chromosomal Region 11q13.5
Acta Electronica Universitatis Tamperensis; 2016
http://urn.fi/URN:ISBN:978-952-03-0126-2 |
Mauro Scaravilli
Identification of 1p21-22 Amplification in Bladder Cancer and Expression of non-coding RNAs in Prostate Cancer
Acta Electronica Universitatis Tamperensis; 22016
http://urn.fi/URN:ISBN:978-952-03-0045-6 |
Sanna Siltanen
Contribution of the ARLTS1 Gene to Prostate Cancer Susceptibility
Acta Electronica Universitatis Tamperensis; 1325, 2013
http://urn.fi/URN:ISBN:978-951-44-9194-8 |
Tuomas Kilpeläinen
Population-Based Screening for Prostate Cancer – Weighing up the beneficial and adverse effects of screening
Acta Universitatis Tamperensis : 1745, 2012
http://urn.fi/urn:isbn:978-951-44-8974-7 |
Saara Lehmusvaara
Traditional and Novel Treatments for Prostate Cancer – Discoveries at the molecular level
Acta Universitatis Tamperensis : 1745, 2012
http://urn.fi/urn:isbn:978-951-44-8845-0 |
Sanni Jalava
The role of 8q amplification and microRNAs in prostate cancer
Acta Universitatis Tamperensis : 1733, 2012
http://urn.fi/urn:isbn:978-951-44-8814-6 |
Alfonso Urbanucci
Overexpression of Androgen Receptor in Prostate Cancer
Acta Universitatis Tamperensis : 1693, 2012
http://urn.fi/urn:isbn:978-951-44-8686-9 |
Teemu Tolonen
Molecular biomarkers and histopathological parameters in prostate cancer diagnostics and prognostics
Acta Universitatis Tamperensis; 1620, 2011
http://urn.fi/urn:isbn:978-951-44-8467-4 |
Sanna Pakkanen
Profiling of High-risk Prostate Cancer Families in Finland
Acta Universitatis Tamperensis : 1553, 2010
http://urn.fi/urn:isbn:978-951-44-8225-0 |
Kati Kivinummi (nee. Waltering)
Androgen receptor signaling pathway in prostate cancer
Acta Universitatis Tamperensis; 1541, 2010
http://urn.fi/urn:isbn:978-951-44-8180-2 |
Teemu Murtola
Prostate cancer incidence among men using statins, finasteride or antidiabetic drugs.
Acta Universitatis Tamperensis Vol 1482, 2009
http://urn.fi/urn:isbn:978-951-44-7926-7 |
Henna Mattila
Hereditary prostate cancer in Finland – From genetic linkage to susceptibility genes.
Acta Universitatis Tamperensis Vol 1475, 2009.
http://urn.fi/urn:isbn:978-951-44-7909-0 |
Hanna Rauhala
DNA hypermethylation in prostate cancer.
Acta Universitatis Tamperensis Vol 1467, 2009.
http://urn.fi/urn:isbn:978-951-44-7884-0 |
Sari Laitinen
Prostate cancer: from molecular genetics to prognostic markers
Acta Universitatis Tamperensis. Vol 1296, 2008.
http://urn.fi/urn:isbn:978-951-44-7247-3 |
Tuukka Mäkinen
The Finnish population-based prostate cancer screening trial.
Acta Universitatis Tamperensis Vol 1352, 2008. |
Liisa Määttänen
Performance of the Finnish prostate cancer screening trial based on process indicators.
Acta Universitatis Tamperensis Vol 1247, 2007 |
Eija Seppälä
Heterogeneity in genetic susceptibility to prostate cancer.
Acta Univesitatis Tamperensis. Vol 1188, 2006.
http://urn.fi/urn:isbn:951-44-6769-8 |
Outi Saramäki
Gene copy number alterations in prostate cancer.
Acta Universitatis Tamperensis. Vol 1162, 2006.
http://urn.fi/urn:isbn:951-44-6679-9 |
Kimmo Savinainen
Amplification and overexpression of ERBB2, uPA, TRPS1, EIF3S3 and MYC genes in prostate cancer.
Acta Universitatis Tamperensis. Vol 1135, 2006.
http://urn.fi/urn:isbn:951-44-6568-7 |
Nina Mononen
Polymorphisms in genes associated with androgen biosynthesis and metabolism as risk factors for human prostate cancer.
Acta Universitatis Tamperensis. Vol 1108, 2005.
http://urn.fi/urn:isbn:951-44-6434-6 |
Annika Rökman
In search of high-penetrant hereditary prostate cancer susceptibility genes in Finland.
Acta Universitatis Tamperensis. Vol 1048, 2004.
http://urn.fi/urn:isbn:951-44-6142-8 |
Kati Porkka
Differentially expressed genes in prostate cancer.
Acta Universitatis Tamperensis. Vol 959, 2003.
http://urn.fi/urn:isbn:951-44-5772-2
|
Marika Linja
Alterations in androgen receptor, estrogen receptors and their coregulatory genes in prostate cancer.
Acta Universitatis Tamperensis. Vol 953, 2003.
http://urn.fi/urn:isbn:951-44-5748-X |
Mika Matikainen
Genetic epidemiology of hereditary prostate cancer in Finland.
Acta Universitatis Tamperensis. Vol 812, 2001.
http://urn.fi/urn:isbn:951-44-5084-1 |
Christian Palmberg
Androgen sensitivity of prostate cancer: special reference to prognostic factors and androgen receptor gene amplification.
Acta Universitatis Tamperensis. Vol 779, 2000.
http://urn.fi/urn:isbn:951-44-4954-1 |
Nina Nupponen
Amplification of EIF3S3 in breast and prostate cancer: from characterization of chromosomal alterations to identification of an amplified target gene.
Acta Universitatis Tamperensis. Vol 712, 1999.
http://urn.fi/urn:isbn:951-44-4700-X |
Pasi Koivisto
Androgen receptor gene amplification in hormone-refractory prostate cancer.
Acta Universitatis Tamperensis. Vol 565, 1997 |
Eija Hyytinen
Molecular cytogenetics of prostate cancer: technology development and analysis of tumor progression.
Acta Universitatis Tamperensis. Ser A, vol 505, 1996.
|
Tapio Visakorpi
Cell proliferation rate in prostatic carcinomas: prognostic value and relation to epidermal growth factor receptor and p53 expression.
Acta Universitatis Tamperensis. Ser A, vol 342, 1992. |